Newer insulin may reduce low blood sugar in youth with type 1 diabetes. A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogs in low-resource settings.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogs in low-resource settings.
- Ponto de atenção: newer.
- Ponto de atenção: insulin.
- Ponto de atenção: reduce.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/a3030f3c-45cb-45f2-84a8-8b29673fabad.jpeg)